Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels

被引:41
作者
Hamalainen, Markku D. [1 ]
Zhukov, Andrei [1 ]
Ivarsson, Maria [1 ]
Fex, Tomas [2 ]
Gottfries, Johan [2 ]
Karlsson, Robert [1 ]
Bjorsne, Magnus [2 ]
机构
[1] GE Co, Healthcare Biosci, R&D, Dept Syst & Applicat, S-75184 Uppsala, Sweden
[2] AstraZeneca, R&D, Molndal, Sweden
关键词
label-free screening; fragment library; protein; high-throughput screening;
D O I
10.1177/1087057108314651
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The authors present fragment screening data obtained using a label-free parallel analysis approach where the binding of fragment library compounds to 4 different target proteins can be screened simultaneously using surface plasmon resonance detection. They suggest this method as a first step in fragment screening to identify and select binders, reducing the demanding requirements on subsequent X-ray or nuclear magnetic resonance studies, and as a valuable "clean-up" tool to eliminate unwanted promiscuous binders from libraries. A small directed fragment library of known thrombin binders and a general 500-compound fragment library were used in this study. Thrombin, blocked thrombin, carbonic anhydrase, and glutathione-S-transferase were immobilized on the sensor chip surface, and the direct binding of the fragments was studied in real time. Only 12 mu g of each protein is needed for screening of a 3000-compound fragment library. For screening, a binding site-blocked target as reference facilitates the identification of binding site-selective hits and the signals from other reference proteins for the elimination of false positives. The scope and limitations of this screening approach are discussed for both target-directed and general fragment libraries.
引用
收藏
页码:202 / 209
页数:8
相关论文
共 14 条
[1]   Ligand efficiency indices as guideposts for drug discovery [J].
Abad-Zapatero, C ;
Metz, JT .
DRUG DISCOVERY TODAY, 2005, 10 (07) :464-469
[2]   Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening [J].
Boehm, HJ ;
Boehringer, M ;
Bur, D ;
Gmuender, H ;
Huber, W ;
Klaus, W ;
Kostrewa, D ;
Kuehne, H ;
Luebbers, T ;
Meunier-Keller, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2664-2674
[3]   A decade of fragment-based drug design: strategic advances and lessons learned [J].
Hajduk, Philip J. ;
Greer, Jonathan .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (03) :211-219
[4]   Ligand efficiency: a useful metric for lead selection [J].
Hopkins, AL ;
Groom, CR ;
Alex, A .
DRUG DISCOVERY TODAY, 2004, 9 (10) :430-431
[5]   A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions [J].
Huber, W .
JOURNAL OF MOLECULAR RECOGNITION, 2005, 18 (04) :273-281
[6]   Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology [J].
Huber, Walter ;
Mueller, Francis .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (31) :3999-4021
[7]   Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries [J].
Inglese, James ;
Auld, Douglas S. ;
Jadhav, Ajit ;
Johnson, Ronald L. ;
Simeonov, Anton ;
Yasgar, Adam ;
Zheng, Wei ;
Austin, Christopher P. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (31) :11473-11478
[8]   Fragment screening: an introduction [J].
Leach, Andrew R. ;
Hann, Michael M. ;
Burrows, Jeremy N. ;
Griffen, Ed J. .
MOLECULAR BIOSYSTEMS, 2006, 2 (09) :430-446
[9]   Statistical molecular design of building blocks for combinatorial chemistry [J].
Linusson, A ;
Gottfries, J ;
Lindgren, F ;
Wold, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (07) :1320-1328
[10]   Statistical molecular design, parallel synthesis, and biological evaluation of a library of thrombin inhibitors [J].
Linusson, A ;
Gottfries, J ;
Olsson, T ;
Örnskov, E ;
Folestad, S ;
Nordén, B ;
Wold, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (21) :3424-3439